Panel Discussion: Perspectives on the State of EU & US Radiopharmaceutical Regulation

Time: 3:30 pm
day: Day One


Panel of Industry Regulatory Staff, Clinicians, Radiopharmacists, Technologists and Regulatory Consultants to discuss how EU regulation has changed over the past year and what changes they are expecting in the coming 12 months:
• EMA regulation of radiopharmaceuticals and country-specific differences in radiopharmaceutical regulation
• Ripple effects from the FDA marketing approval of Pluvitco
• What can we educate the regulators on to help reform policy on RLT in the EU?